OM Pharma to unveil major real-world evidence breakthrough on Broncho-Vaxom at EAACI
The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months
The company will unveil preliminary findings showing that Broncho-Vaxom was associated with a 28–38% reduction in respiratory tract infection rates at 12 months
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
Indian Pharmacopoeia Commission hosts scientific conclave to brainstorm on strengthening pharmaceutical quality and compliance
The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
The investment will bring in cutting-edge downstream fermentation technology, strengthening the company’s contract manufacturing capabilities for drug substances
Novo Nordisk continues to position Wegovy as a cornerstone of its obesity treatment portfolio
Strong performances in its Life Science, Healthcare and Electronics divisions — particularly Process Solutions, Cardiovascular treatments and Semiconductor Materials — powered the company’s results
Chemicals delivered improved efficiency and optimal capacity utilization, with EBIT rising 37% YoY
Projects selected for advancement will move forward through the Harvard Office of Technology Development’s processes for sponsored research agreements
Subscribe To Our Newsletter & Stay Updated